Table of Content

1 Introduction 5
1.1 Industry Definition and Research Scope 5
1.1.1 Industry Definition 5
1.1.2 Research Scope 6
1.2 Research Methodology 9
1.2.1 Overview of Market Research Methodology 9
1.2.2 Market Assumption 10
1.2.3 Secondary Data 10
1.2.4 Primary Data 10
1.2.5 Data Filtration and Model Design 12
1.2.6 Market Size/Share Estimation 13
1.2.7 Research Limitations 14
1.3 Executive Summary 15

2 Market Overview and Dynamics 17
2.1 Market Size and Forecast 17
2.1.1 Impact of COVID-19 on the Market 18
2.2 Major Growth Drivers 20
2.3 Market Restraints and Challenges 24
2.4 Emerging Opportunities and Market Trends 27
2.5 Porter’s Fiver Forces Analysis 31

3 Segmentation of Asia Pacific Market by Product Type 35
3.1 Market Overview by Product Type 35
3.2 Oseltamivir Phosphate 37
3.3 Baloxavir Marboxil 38
3.4 Peramivir 39
3.5 Zanamivir 40
3.6 Other Drugs 41

4 Segmentation of Asia Pacific Market by Influenza Type 42
4.1 Market Overview by Influenza Type 42
4.2 Influenza A 44
4.3 Influenza B 45
4.4 Influenza C 46

5 Segmentation of Asia Pacific Market by Administration Route 47
5.1 Market Overview by Administration Route 47
5.2 Oral Administration 49
5.3 Other Administration Routes 50

6 Segmentation of Asia Pacific Market by Distribution Channel 51
6.1 Market Overview by Distribution Channel 51
6.2 Retail Pharmacy 53
6.3 Hospital Pharmacy 54
6.4 Clinics 55
6.5 Online Stores 56

7 Asia-Pacific Market 2019-2030 by Country 57
7.1 Overview of Asia-Pacific Market 57
7.2 Japan 60
7.3 China 63
7.4 Australia 65
7.5 India 67
7.6 South Korea 69
7.7 Rest of APAC Region 71

8 Competitive Landscape 73
8.1 Overview of Key Vendors 73
8.2 New Product Launch, Partnership, Investment, and M&A 76
8.3 Company Profiles 77
AstraZeneca Plc 77
BioCryst Pharmaceuticals Inc. 79
Biondvax 80
Daiichi Sankyo Company 81
F. Hoffmann-La Roche Ltd. (Genentech USA, Inc.) 82
GlaxoSmithKline Plc 83
Mylan N.V 84
Natco Pharma Limited 85
Novartis AG 86
Sanofi 87
Seqirus 88
Teva Pharmaceutical Industries Limited 89

9 Investing in Asia Pacific Market: Risk Assessment and Management 90
9.1 Risk Evaluation of Asia Pacific Market 90
9.2 Critical Success Factors (CSFs) 93
Related Reports and Products 96



List of Figures


Figure 1. Research Method Flow Chart 9
Figure 2. Breakdown of Primary Research 11
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation 13
Figure 4. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030 15
Figure 5. Asia Pacific Influenza Treatment Market, 2019-2030, $ mn 17
Figure 6. Impact of COVID-19 on Business 18
Figure 7. Primary Drivers and Impact Factors of Asia Pacific Influenza Treatment Market 20
Figure 8. GDP per capita in the World, 1960-2018, $ thousand 23
Figure 9. Forecast of Middle-class Population by Region, 2015-2030, million 23
Figure 10. Primary Restraints and Impact Factors of Asia Pacific Influenza Treatment Market 24
Figure 11. Investment Opportunity Analysis 28
Figure 12. Porter’s Fiver Forces Analysis of Asia Pacific Influenza Treatment Market 31
Figure 13. Breakdown of Asia Pacific Influenza Treatment Market by Product Type, 2019-2030, % of Revenue 35
Figure 14. Asia Pacific Addressable Market Cap in 2020-2030 by Product Type, Value ($ mn) and Share (%) 36
Figure 15. Asia Pacific Influenza Treatment Market: Oseltamivir Phosphate, 2019-2030, $ mn 37
Figure 16. Asia Pacific Influenza Treatment Market: Baloxavir Marboxil, 2019-2030, $ mn 38
Figure 17. Asia Pacific Influenza Treatment Market: Peramivir, 2019-2030, $ mn 39
Figure 18. Asia Pacific Influenza Treatment Market: Zanamivir, 2019-2030, $ mn 40
Figure 19. Asia Pacific Influenza Treatment Market: Other Drugs, 2019-2030, $ mn 41
Figure 20. Breakdown of Asia Pacific Influenza Treatment Market by Influenza Type, 2019-2030, % of Sales Revenue 42
Figure 21. Asia Pacific Addressable Market Cap in 2020-2030 by Influenza Type, Value ($ mn) and Share (%) 43
Figure 22. Asia Pacific Influenza Treatment Market: Influenza A, 2019-2030, $ mn 44
Figure 23. Asia Pacific Influenza Treatment Market: Influenza B, 2019-2030, $ mn 45
Figure 24. Asia Pacific Influenza Treatment Market: Influenza C, 2019-2030, $ mn 46
Figure 25. Breakdown of Asia Pacific Influenza Treatment Market by Administration Route, 2019-2030, % of Sales Revenue 47
Figure 26. Asia Pacific Addressable Market Cap in 2020-2030 by Administration Route, Value ($ mn) and Share (%) 48
Figure 27. Asia Pacific Influenza Treatment Market: Oral Administration, 2019-2030, $ mn 49
Figure 28. Asia Pacific Influenza Treatment Market: Other Administration Routes, 2019-2030, $ mn 50
Figure 29. Breakdown of Asia Pacific Influenza Treatment Market by Distribution Channel, 2019-2030, % of Revenue 51
Figure 30. Asia Pacific Addressable Market Cap in 2020-2030 by Distribution Channel, Value ($ mn) and Share (%) 52
Figure 31. Asia Pacific Influenza Treatment Market: Retail Pharmacy, 2019-2030, $ mn 53
Figure 32. Asia Pacific Influenza Treatment Market: Hospital Pharmacy, 2019-2030, $ mn 54
Figure 33. Asia Pacific Influenza Treatment Market: Clinics, 2019-2030, $ mn 55
Figure 34. Asia Pacific Influenza Treatment Market: Online Stores, 2019-2030, $ mn 56
Figure 35. Breakdown of APAC Influenza Treatment Market by Country, 2019 and 2030, % of Revenue 58
Figure 36. Contribution to APAC 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%) 59
Figure 37. Influenza Treatment Market in Japan, 2019-2030, $ mn 61
Figure 38. Influenza Treatment Market in China, 2019-2030, $ mn 63
Figure 39. Influenza Treatment Market in Australia, 2019-2030, $ mn 65
Figure 40. Influenza Treatment Market in India, 2019-2030, $ mn 67
Figure 41. Influenza Treatment Market in South Korea, 2019-2030, $ mn 69
Figure 42. Influenza Treatment Market in Rest of APAC, 2019-2030, $ mn 71
Figure 43. Growth Stage of Asia Pacific Influenza Treatment Industry over the Forecast Period 73


List of Tables


Table 1. Snapshot of Asia Pacific Influenza Treatment Market, 2019-2030 16
Table 2. Main Product Trends and Market Opportunities in Asia Pacific Influenza Treatment Market 27
Table 3. Asia Pacific Influenza Treatment Market by Product Type, 2019-2030, $ mn 35
Table 4. Asia Pacific Influenza Treatment Market by Influenza Type, 2019-2030, $ mn 42
Table 5. Asia Pacific Influenza Treatment Market by Administration Route, 2019-2030, $ mn 47
Table 6. Asia Pacific Influenza Treatment Market by Distribution Channel, 2019-2030, $ mn 51
Table 7. APAC Influenza Treatment Market by Country, 2019-2030, $ mn 58
Table 8. Japan Influenza Treatment Market by Product Type, 2019-2030, $ mn 62
Table 9. Japan Influenza Treatment Market by Administration Route, 2019-2030, $ mn 62
Table 10. Japan Influenza Treatment Market by Distribution Channel, 2019-2030, $ mn 62
Table 11. China Influenza Treatment Market by Product Type, 2019-2030, $ mn 64
Table 12. China Influenza Treatment Market by Administration Route, 2019-2030, $ mn 64
Table 13. China Influenza Treatment Market by Distribution Channel, 2019-2030, $ mn 64
Table 14. Australia Influenza Treatment Market by Product Type, 2019-2030, $ mn 66
Table 15. Australia Influenza Treatment Market by Administration Route, 2019-2030, $ mn 66
Table 16. Australia Influenza Treatment Market by Distribution Channel, 2019-2030, $ mn 66
Table 17. India Influenza Treatment Market by Product Type, 2019-2030, $ mn 68
Table 18. India Influenza Treatment Market by Administration Route, 2019-2030, $ mn 68
Table 19. India Influenza Treatment Market by Distribution Channel, 2019-2030, $ mn 68
Table 20. South Korea Influenza Treatment Market by Product Type, 2019-2030, $ mn 70
Table 21. South Korea Influenza Treatment Market by Administration Route, 2019-2030, $ mn 70
Table 22. South Korea Influenza Treatment Market by Distribution Channel, 2019-2030, $ mn 70
Table 23. Influenza Treatment Market in Rest of APAC by Country, 2019-2030, $ mn 72
Table 24. AstraZeneca Plc: Company Snapshot 77
Table 25. AstraZeneca Plc: Business Segmentation 77
Table 26. AstraZeneca Plc: Product Portfolio 78
Table 27. AstraZeneca Plc: Revenue, 2016-2018, $ mn 78
Table 28. AstraZeneca Plc: Recent Developments 78
Table 29. Risk Evaluation for Investing in Asia Pacific Market, 2019-2030 91
Table 30. Critical Success Factors and Key Takeaways 94